4.4 Review

Scorpion venom components as potential candidates for drug development

Journal

TOXICON
Volume 93, Issue -, Pages 125-135

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.toxicon.2014.11.233

Keywords

Anticancer peptides; Antimicrobials; Bradykinin-potentiating peptides; Drug candidates; Immune-modulators; Scorpion venom

Funding

  1. Mexican Council of Science and Technology (CONACyT) of Mexico [153496, 122094]
  2. Brazilian National Council of Research (CNPq)
  3. Direccion General de Asuntos del Personal Academiaco (DGAPA) of UNAM [IN200113]
  4. CNPq [306524/2012-0]

Ask authors/readers for more resources

Scorpions are well known for their dangerous stings that can result in severe consequences for human beings, including death. Neurotoxins present in their venoms are responsible for their toxicity. Due to their medical relevance, toxins have been the driving force in the scorpion natural compounds research field. On the other hand, for thousands of years, scorpions and their venoms have been applied in traditional medicine, mainly in Asia and Africa. With the remarkable growth in the number of characterized scorpion venom components, several drug candidates have been found with the potential to tackle many of the emerging global medical threats. Scorpions have become a valuable source of biologically active molecules, from novel antibiotics to potential anticancer therapeutics. Other venom components have drawn attention as useful scaffolds for the development of drugs. This review summarizes the most promising candidates for drug development that have been isolated from scorpion venoms. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available